<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR5">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hill</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Khoo</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Fortunak</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Simmons</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Ford</surname>
    <given-names>N</given-names>
   </name>
  </person-group>
  <article-title>Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries</article-title>
  <source>Clin Infect Dis</source>
  <year>2014</year>
  <volume>58</volume>
  <issue>7</issue>
  <fpage>928</fpage>
  <lpage>936</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/ciu012</pub-id>
  <?supplied-pmid 24399087?>
  <pub-id pub-id-type="pmid">24399087</pub-id>
 </element-citation>
</ref>
